At AAPS PharmSci 360 2025, held from Nov. 9–12 in San Antonio, Texas, Corey Bloom, PhD, associate director, CMC (chemistry, ...

Using Ascletis' proprietary Ultra-Long-Acting Platform technology, co-formulation of ASC36, a once-monthly subcutaneously administered amylin receptor peptide agonist and ASC35, a once-monthly ...

The aim of any formulation scientist is to create a product that is safe, effective, stable, and distinct from competitor drugs. It also helps if the product is as patient friendly as possible to ...

(MENAFN- GlobeNewsWire - Nasdaq) The United States Formulation Development Outsourcing Market is set to surge from US$ 10.11 billion in 2024 to US$ 18.11 billion by 2033, growing at a CAGR of 6.69%.

Aptuit said today it has acquired Kuecept for an undisclosed price, in a deal the buyer said would help it meet customer demand for specialist drug preformulation, formulation prototyping, and ...

TORONTO, January 10, 2023 [Embargo 10 a.m. London Time] – Scientists at the University of Toronto have successfully tested the use of machine learning models to guide the design of long-acting ...

SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...

The funding round was led by Spero Ventures with participation from MBX Capital, Shimadzu Future Innovation Fund managed by Global Brain Corporation, Eli Lilly & Company, SignalFire, Ford Street ...

Scientists have successfully tested the use of machine learning models to guide the design of long-acting injectable drug formulations. The potential for machine learning algorithms to accelerate drug ...

Dublin, Oct. 28, 2025 (GLOBE NEWSWIRE) -- The "United States Formulation Development Outsourcing Market Report by Service, Formulation, Therapeutic Area, End Use, States and Company Analysis, ...